Back

Cancer Medicine

17 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Application of a Concise Video to Improve Patient Understanding of Tumor Genomic Testing in Community and Academic Practice Settings
2026-03-06 oncology 10.64898/2026.03.05.26347758
#1 (6.0%)
Show abstract

Purpose: Tumor genomic testing (TGT) is standard-of-care for most patients with advanced/metastatic cancer. Despite established guidelines, patient education prior to TGT is frequently omitted. The purpose of this study was to evaluate the impact and durability of a concise 3-4 minute video for patient education prior to TGT in community versus academic sites and across cancer types. Patients and Methods: Patients undergoing standard-of-care TGT were enrolled at a tertiary academic institution ...

2
Performance of an Optimized Methylation-Protein Multi-Cancer Early Detection (MCED) Test Classifier
2026-03-04 oncology 10.64898/2026.03.03.26347329
Top 0.3% (5.1%)
Show abstract

Multi-cancer early detection (MCED) tests can detect several cancer types and stages. We previously developed a methylation and protein (MP V1) MCED classifier. In this study, we present a refined MP V2 classifier, developed by evaluating model architectures that improved performance in prospectively enrolled case-control cohorts under standard testing conditions. The newly developed MP V2 classifier was trained to be more generalizable and achieve increased early-stage sensitivity at a target s...

3
Onco-Shikshak: An AI-Native Adaptive Learning Ecosystem for Medical Oncology Education
2026-02-26 oncology 10.64898/2026.02.23.26346944
Top 0.3% (5.1%)
Show abstract

Medical oncology education faces a dual crisis: knowledge velocity that outpaces static curricula and large language model (LLM) risks--hallucination and automation bias--that threaten the fidelity of AI-assisted learning. We present Onco-Shikshak V7, an AI-native adaptive learning platform that addresses both challenges through a unified cognitive architecture grounded in learning science. The system replaces isolated educational modules with four authentic clinical workflows--Morning Report, T...

4
OncoRAG: Graph-Based Retrieval Enabling Clinical Phenotyping from Oncology Notes Using Local Mid-Size Language Models
2026-03-06 oncology 10.64898/2026.03.05.26347717
Top 0.4% (4.9%)
Show abstract

Introduction: Manual data extraction from unstructured clinical notes is labor-intensive and impractical for large-scale clinical and research operations. Existing automated approaches typically require large language models, dedicated computational infrastructure, and/or task-specific fine-tuning that depends on curated data. The objective of this study is to enable accurate extraction with smaller locally deployed models using a disease-site specific pipeline and prompt configuration that are ...

5
Cohort Profile: The Adolescent and Young Adult Tracking Engagement and Management Skills (AYA TEAMS) Longitudinal Cohort of Childhood Cancer Survivors in the United States
2026-02-14 oncology 10.64898/2026.02.11.26346092
Top 0.4% (4.8%)
Show abstract

PurposeTo describe the rationale, methods, and baseline sample descriptives of the Adolescent and Young Adult Tracking Engagement and Management Skills (AYA TEAMS) cohort. The AYA TEAMS study is a longitudinal observational cohort study that aims to identify determinants and patterns of self-management and engagement in cancer-related long-term follow-up (LTFU) care and validate a novel transition readiness assessment among adolescent and young adult (AYA) survivors of childhood cancer. Partici...

6
Fertility in the Shadow of Cancer: Experiences of Reproductive Loss Among Women with Gynecological Cancers in Ghana
2026-02-28 oncology 10.64898/2026.02.21.26346234
Top 0.5% (4.5%)
Show abstract

BackgroundGynecological cancers and their treatments can compromise fertility, with profound psychosocial consequences for women of reproductive age. Yet, womens lived experiences of cancer-related infertility remain underexplored in low-resource settings, including Ghana. This study examined the impact of gynecological cancers on fertility among reproductive-aged women receiving care at Ho Teaching Hospital, Ghana. MethodsA qualitative descriptive design was used. Fourteen women aged 15-49 yea...

7
Survey shows limited awareness of tamoxifen-associated uterine cancer risk among breast cancer survivors
2026-02-17 oncology 10.64898/2026.02.16.26346375
Top 0.5% (4.4%)
Show abstract

BackgroundTamoxifen is a cornerstone of endocrine treatment for hormone receptor-positive breast cancer, reducing recurrence and breast cancer-specific mortality. However, its use is associated with a small, yet clinically relevant, increase in uterine cancer. As diagnosis of this cancer remains symptom-triggered, it is essential for patients to be aware of this risk and report symptoms promptly for optimal outcomes. We therefore assessed risk awareness among breast cancer survivors while explor...

8
Integration of a Molecular Prognostic Classifier into the Ninth Edition TNM Staging of Lung Adenocarcinoma
2026-02-18 oncology 10.64898/2026.02.17.26346484
Top 0.5% (4.4%)
Show abstract

IntroductionDespite advancements in non-small cell lung cancer (NSCLC) management through the use of molecular biomarkers, the recently introduced 9th edition of the TNM staging system remains based exclusively on anatomic descriptors, with no consistently demonstrated improvement in risk stratification for early-stage disease. This study explores the integration of a molecular prognostic classifier into the conventional TNM staging system. MethodsWe analyzed 502 patients with stage I-III lung ...

9
Prognostic Significance of Cerebrospinal Fluid Glucose, Protein, and White Blood Cell Count in Breast Cancer Leptomeningeal Disease.
2026-02-09 oncology 10.64898/2026.02.07.26345775
Top 0.5% (4.3%)
Show abstract

BackgroundLeptomeningeal disease (LMD) is a serious complication of metastatic breast cancer (MBC) with poor survival. This single-institution retrospective study compares overall survival (OS) among MBC patients with LMD based on CSF parameters (glucose, protein, and WBC count) MethodologyMBC patients who were diagnosed with LMD between 2010-2023 at Wilmot Cancer Institute were screened for eligibility. Only those with available data on CSF glucose, protein, and WBC count were included. OS was...

10
Interdependent Patient-Reported Outcome Patterns During Breast Cancer Pharmacotherapy: A Correlation-Based Analysis Using EORTC QLQ-C30 and QLQ-BR23
2026-02-11 oncology 10.64898/2026.02.10.26345961
Top 0.6% (4.3%)
Show abstract

BackgroundQuality-of-life (QoL) assessment is essential in breast cancer care, yet limited evidence describes how interrelated QoL domains change during pharmacotherapy. This study aimed to evaluate correlations among functional and symptom scales using the EORTC QLQ-C30 and QLQ-BR23, highlighting their ability to reveal multidimensional QoL patterns. MethodsA prospective observational study was conducted in two second-referral hospitals in Indonesia, enrolling 106 female breast cancer patients...

11
Genomic characterization of upper urinary tract urothelial carcinoma and clonal evolution of intravesical recurrences
2026-02-18 oncology 10.64898/2026.02.18.26346396
Top 0.6% (4.2%)
Show abstract

Background and ObjectivePatients with upper urinary tract urothelial carcinoma (UTUC) undergoing radical surgery are at high risk of developing intravesical recurrences (IVR). The biology of IVR after surgery for UTUC is poorly understood, and urine markers to replace cystoscopic surveillance of the bladder are lacking. Here, we characterized the genomic landscape of UTUC and paired IVR to discover therapeutic targets and identify diagnostic markers for IVR. MethodsWe performed targeted next-ge...

12
Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis due to radiotherapy for head and neck cancer
2026-02-28 oncology 10.64898/2026.02.26.26347195
Top 0.6% (4.2%)
Show abstract

PurposeThis study evaluated the safety and effectiveness of an intraoral light-emitting diode (LED)-based photobiomodulation (PBM) device to reduce the incidence and severity of oral mucositis (OM) from intensity modulated radiation therapy (IMRT) for head and neck cancer (HNC). MethodsThis randomized, double-blind, sham-controlled trial enrolled patients with HNC undergoing high-dose IMRT over 6-8 weeks, with or without concurrent chemotherapy. Participants received daily 10-minute PBM or sham...

13
Within-Group Racial and Ethnic Differences in County-Level Socio-Behavioral Risk Across Cancer Mortality Tertiles in the United States
2026-02-26 oncology 10.64898/2026.02.24.26347030
Top 0.7% (4.1%)
Show abstract

ImportancePersistent racial and ethnic disparities in breast and prostate cancer mortality are well documented. Most prior studies emphasize between-group differences and rely on population averages or single composite measures of social disadvantage, which can obscure high-need communities within groups. How socio-behavioral determinants of health vary within groups across local gradients of cancer mortality remains incompletely characterized. A framework that combines race- and cancer-specific...

14
GALEAS™ Bladder Demonstrates High Sensitivity and Specificity for Detecting Bladder Cancer: Real-World Multicentre Data from UK NHS Haematuria Clinics
2026-02-09 oncology 10.64898/2026.02.06.26345752
Top 1.0% (4.0%)
Show abstract

BackgroundCystoscopy is a core component of haematuria investigations but is invasive and resource-intensive. GALEAS Bladder is a DNA-based diagnostic urine test that measures alterations in 23 bladder cancer-associated genes. ObjectiveTo assess the diagnostic performance and clinical utility of GALEAS Bladder as a molecular triage tool in real-world haematuria investigation pathways. MethodsPatients referred for urgent investigation of haematuria were prospectively enrolled across seven UK NH...

15
Optimizing Gastric Cancer Treatment: The Role of LODDs in Lymph Node Staging
2026-02-24 oncology 10.64898/2026.02.22.26346844
Top 1% (3.9%)
Show abstract

BackgroundGastric cancer is one of the most common malignancies worldwide and is associated with poor prognosis, placing a considerable burden on public health. Overall treatment outcomes remain unsatisfactory, and accurate lymph node staging is essential for optimizing therapeutic strategies and improving survival. This study aimed to compare the prognostic value of different lymph node staging systems in patients with gastric adenocarcinoma and to provide a more refined prognostic assessment t...

16
Germline sequencing in children with cancer in Quebec: an integrated investigative approach
2026-02-10 oncology 10.64898/2026.02.10.26345751
Top 1% (3.9%)
Show abstract

BackgroundThe province of Quebec has progressively implemented paired tumour-germline sequencing in paediatric oncology through two coordinated precision research programs, preceding a province-wide mainstream clinical genomics initiative. We report the prevalence, spectrum, and clinical relevance of germline findings (GFs) in children with primary extracranial cancers, integrating molecular, phenotypic, and pathological data. MethodsPatients enrolled between 2014 and 2022 underwent germline wh...

17
Prognostic Impact of Embryonal and Yolk Sac Components in Metastatic Germ Cell Tumors. Insights from an International Cohort.
2026-02-12 oncology 10.64898/2026.02.10.26345982
Top 1% (3.9%)
Show abstract

PurposePrognosis in metastatic non-seminomatous germ cell tumors (mNSGCT) is currently guided by the IGCCCG classification, which incorporates tumor markers, organs involved with metastatic disease, and primary site but not histologic subtype. We aimed to evaluate whether specific histological components provide additional prognostic information in a large international mNSGCT cohort. Patient and MethodsWe analyzed clinical, pathologic, and outcome data from 662 patients with mNSGCT across mult...

18
A Czech national administrative real-world study of diagnostics and treatment pathways of non-small-cell lung cancer stratified by disease stage: From data to actionable indicators
2026-02-25 oncology 10.64898/2026.02.20.26346704
Top 1% (3.9%)
Show abstract

IntroductionBuilding on our previously published methodology for claims-based pathway mapping, we extended the analysis by incorporating disease staging. The aim of this study was to develop and evaluate quality indicators (QIs) in patients with non-small cell lung cancer (NSCLC). MethodsThis retrospective, longitudinal cohort study spanned 2017-2023, with follow-up data extending to September 2025. Data were obtained from the National Cancer Registry (NCR), the National Registry of Reimbursed ...

19
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology Trials
2026-02-10 oncology 10.64898/2026.02.08.26345855
Top 1% (3.8%)
Show abstract

BackgroundResearch infra-structure is essential for conducting phase III cancer clinical trials as its lack precludes trial availability and its maturity may influence the portfolio of available options. Several studies have highlighted global disparities, but none has ever mapped the worldwide network of research facilities conducting such trials. MethodsWe extracted all research sites within recruiting phase III cancer interventional trials from the ClinicalTrials.gov database on July 23, 202...

20
A Mixed Probiotic/Prebiotic Intervention (MBR 01) for the Management of Diarrhea During Abemaciclib Treatment of Early Breast Cancer: A Single Center Prospective Case Control Pilot Study
2026-02-17 oncology 10.64898/2026.02.13.26346277
Top 1% (3.8%)
Show abstract

BackgroundAdjuvant abemaciclib+endocrine therapy (ET) improves long-term outcomes in high-risk, hormone receptor-positive (HR+)/HER2-negative early breast cancer (eBC). However, treatment is frequently complicated by diarrhea, affecting adherence and quality of life (QoL). Increasing evidence suggests that abemaciclib-induced gastrointestinal toxicity may involve gut microbiota alterations. We conducted a prospective case-control pilot study evaluating the efficacy of MBR-01, a standardized preb...